- Quarterly
- Annual
- TTM
-
Export .csv
-
Download Image
-
Copy link
-
Embed code
Share URL
Bar Chart preview
Novartis AG Selling, General, and Administrative Expenses (SG&A;) is USD 12.57 B for the year ending December 31, 2024, a 0.39% change year over year. Selling, general, and administrative (SG&A;) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company. Novartis AG Selling, General, and Administrative Expenses (SG&A;) for the year ending December 31, 2023 was USD 12.52 B, a -12.18% change year over year. Novartis AG Selling, General, and Administrative Expenses (SG&A;) for the year ending December 31, 2022 was USD 14.25 B, a -4.25% change year over year. Novartis AG Selling, General, and Administrative Expenses (SG&A;) for the year ending December 31, 2021 was USD 14.89 B, a 4.85% change year over year. Novartis AG Selling, General, and Administrative Expenses (SG&A;) for the year ending December 31, 2020 was USD 14.20 B, a -1.20% change year over year.
Embed chart view
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max